Coronary artery disease
Conditions
Interventions
Digital follow-up group:Digital Clinical Management System
Sponsors
Tangdu Hospital, Fourth Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old=6.2mmol/L, or TG>=2.3mmol/L, or HDL-C<=1.0mmol/L); 4. Patient is willing to follow the study protocol and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. History of moderate to severe valve disease; 2. Patients receiving intra aortic balloon counterpulsation and tracheal intubation; 3. History of dilated cardiomyopathy, perinatal cardiomyopathy, chemotherapy induced cardiomyopathy, hereditary hypertrophic cardiomyopathy, invasive cardiomyopathy, and viral myocarditis; 4. Patients with malignant tumors or those with an expected lifespan of less than 1 year; 5. Serious liver dysfunction (ALT or AST exceeding 3 times the upper limit of the normal range, or total bilirubin>1.5mg/dl) and renal dysfunction (eGFR<30ml/min/1.73m^2) caused by non cardiac reasons; 6. Pregnant women or patients with pregnancy plans within one year; 7. History of drug or alcohol abuse within the past 12 months; 8. Patients with mental illness or unable to cooperate in completing the study; 9. Individuals with disabilities in using smartphones; 10. Participate in other clinical studies within one month prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Device-oriented composite endpoints; | — |
Secondary
| Measure | Time frame |
|---|---|
| All-Cause Mortality;Indicators (blood pressure, heart rate, LDL) attainment rate;Readmission rate for cardiovascular disease;In stent restenosis and in stent thrombosis;MACE event; | — |
Countries
China
Contacts
Public ContactLi Yan
Tangdu Hospital, Fourth Military Medical University
Outcome results
None listed